Follow
Alan W. Partin
Alan W. Partin
Verified email at jhmi.edu
Title
Cited by
Cited by
Year
Mortality results from a randomized prostate-cancer screening trial
GL Andriole, ED Crawford, RL Grubb III, SS Buys, D Chia, TR Church, ...
New England journal of medicine 360 (13), 1310-1319, 2009
39762009
Natural history of progression after PSA elevation following radical prostatectomy
CR Pound, AW Partin, MA Eisenberger, DW Chan, JD Pearson, PC Walsh
Jama 281 (17), 1591-1597, 1999
37631999
Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: a multi-institutional update
AW Partin, MW Kattan, ENP Subong, PC Walsh, KJ Wojno, JE Oesterling, ...
Jama 277 (18), 1445-1451, 1997
25521997
Campbell-Walsh Urology E-Book: 4-Volume Set
AJ Wein, LR Kavoussi, AW Partin, CA Peters
Elsevier Health Sciences, 2015
23212015
Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial
WJ Catalona, AW Partin, KM Slawin, MK Brawer, RC Flanigan, A Patel, ...
Jama 279 (19), 1542-1547, 1998
17551998
The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer
AW Partin, J Yoo, HB Carter, JD Pearson, DW Chan, JI Epstein, PC Walsh
The Journal of urology 150 (1), 110-114, 1993
16601993
Risk of prostate cancer–specific mortality following biochemical recurrence after radical prostatectomy
SJ Freedland, EB Humphreys, LA Mangold, M Eisenberger, FJ Dorey, ...
Jama 294 (4), 433-439, 2005
16502005
Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium
AW Partin, LA Mangold, DM Lamm, PC Walsh, JI Epstein, JD Pearson
Urology 58 (6), 843-848, 2001
14722001
Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy: the 15-year Johns Hopkins experience
M Han, AW Partin, CR Pound, JI Epstein, PC Walsh
Urologic Clinics of North America 28 (3), 555-565, 2001
13382001
Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer
R Hu, TA Dunn, S Wei, S Isharwal, RW Veltri, E Humphreys, M Han, ...
Cancer research 69 (1), 16-22, 2009
13092009
Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24
J Gudmundsson, P Sulem, A Manolescu, LT Amundadottir, ...
Nature genetics 39 (5), 631-637, 2007
10182007
Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer
M Han, AW Partin, M Zahurak, S Piantadosi, JI Epstein, PC Walsh
The Journal of urology 169 (2), 517-523, 2003
9932003
Prostate specific antigen: a decade of discovery-what we have learned and where we are going
TJ Polascik, JE Oesterling, AW Partin
The Journal of urology 162 (2), 293-306, 1999
9521999
Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years
PC Walsh, AW Partin, JI Epstein
The Journal of urology 152 (5), 1831-1836, 1994
9201994
Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia
AW Partin, HB Carter, DW Chan, JI Epstein, JE Oesterling, RC Rock, ...
The Journal of urology 143 (4), 747-752, 1990
8751990
Prognostic G leason grade grouping: data based on the modified G leason scoring system
PM Pierorazio, PC Walsh, AW Partin, JI Epstein
BJU international 111 (5), 753-760, 2013
8492013
Germline Mutations in HOXB13 and Prostate-Cancer Risk
CM Ewing, AM Ray, EM Lange, KA Zuhlke, CM Robbins, WD Tembe, ...
New England Journal of Medicine 366 (2), 141-149, 2012
8062012
Prostate-specific antigen after anatomic radical retropubic prostatectomy: patterns of recurrence and cancer control
CR Pound, AW Partin, JI Epstein, PC Walsh
Urologic Clinics of North America 24 (2), 395-406, 1997
7961997
Prostate cancer–specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy
BJ Trock, M Han, SJ Freedland, EB Humphreys, TL DeWeese, AW Partin, ...
Jama 299 (23), 2760-2769, 2008
7832008
Predicting 15-year prostate cancer specific mortality after radical prostatectomy
SE Eggener, PT Scardino, PC Walsh, M Han, AW Partin, BJ Trock, Z Feng, ...
The Journal of urology 185 (3), 869-875, 2011
7582011
The system can't perform the operation now. Try again later.
Articles 1–20